Fishing for Carbon Gems in a Vast Sea of Oversupply: Assessing China’s Carbon Nanotube and Graphene Landscape

January 19, 2014 | State of the Market Report

Favorable government policies and funding support have helped China become the global leader in aggregate graphene and carbon nanotube (CNT) publication and patenting activity. Drawing on this momentum, Chinese companies rushed to scale up production of these two nanomaterials, stimulating fierce competition. Such significant capacity expansions will exacerbate global oversupply in the graphene nanoplatelet (GNP) and CNT markets. At present, GNP and CNT leaders target battery electrodes as their primary target application due to the established, large-volume lithium-ion battery capacity in the country. We compare Chinese developers with their foreign counterparts on the Lux Innovation Grid and find that Chinese graphene suppliers lag global competition on cost, whereas leading Chinese CNT players are on par with their international rivals. Therefore, domestic CNT leaders currently have potential to act as valuable partners, whereas graphene firms should be monitored until concrete value proposition is proven.

Coverage Areas

Table of Contents

  • Executive Summary
  • Landscape
  • Analysis
  • Outlook

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978